U.S. News & World Report

Novartis to Acquire Tourmaline Bio for $1.4 Billion

BERLIN (Reuters) - Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on ...
U.S. News & World Report

Phillips 66 Buys Remaining Stake in Major US Refineries From Cenovus for $1.4 Billion

(Reuters) - Phillips 66 said on Tuesday it will acquire the remaining 50% stake in WRB Refining from Cenovus Energy for $1.4 billion, giving it full ownership of two major U.S. refineries. Shares of ...
Hosted on MSN

Novartis Agrees to Buy Tourmaline Bio in $1.4 Billion-Dollar Deal

Novartis agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted therapy drug pacibekitug. The Swiss pharmaceutical ...
Hosted on MSN

Patagonia founder lived on $1 a day and cat food before making it—when he hit billionaire status, he was so angry he gave away his $3 billion company

For many business leaders, joining the billionaires club is the ultimate badge of success—placing them among the ranks of Warren Buffett, Bill Gates, and Jeff Bezos. However, for Yvon Chouinard, the ...